title: Dampened dopamine-mediated neuromodulation in prefrontal cortex of fragile X mice.
abstract: Fragile X syndrome (FXS) is the most common form of inheritable mental retardation caused by transcriptional silencing of the Fmr1 gene resulting in the absence of fragile X mental retardation protein (FMRP). The role of this protein in neurons is complex and its absence gives rise to diverse alterations in neuronal function leading to neurological disorders including mental retardation, hyperactivity, cognitive impairment, obsessive-compulsive behaviour, seizure activity and autism. FMRP regulates mRNA translation at dendritic spines where synapses are formed, and thus the lack of FMRP can lead to disruptions in synaptic transmission and plasticity. Many of these neurological deficits in FXS probably involve the prefrontal cortex, and in this study, we have focused on modulatory actions of dopamine in the medial prefrontal cortex. Our data indicate that dopamine produces a long-lasting enhancement of evoked inhibitory postsynaptic currents (IPSCs) mediated by D1-type receptors seen in wild-type mice; however, such enhancement is absent in the Fmr1 knock-out (Fmr1 KO) mice. The facilitation of IPSCs produced by direct cAMP stimulation was unaffected in Fmr1 KO, but D1 receptor levels were reduced in these animals. Our results show significant disruption of dopaminergic modulation of synaptic transmission in the Fmr1 KO mice and this alteration in inhibitory activity may provide insight into potential targets for the rescue of deficits associated with FXS.
authors.affiliation: Department of Molecular and Integrative Physiology, University of Illinois, Urbana, IL 61801, USA. kushpaul@illinois.edu
authors.forename: Kush
authors.initials: K
authors.lastname: Paul
authors.forename: Deepa V
authors.initials: DV
authors.lastname: Venkitaramani
authors.forename: Charles L
authors.initials: CL
authors.lastname: Cox
mesh_terms: D000818:Animals; D004298:Dopamine / Q000502:physiology*; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000502:physiology; D005600:Fragile X Syndrome / Q000503:physiopathology*; D053444:Inhibitory Postsynaptic Potentials; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D017397:Prefrontal Cortex / Q000503:physiopathology*; D017966:Pyramidal Cells / Q000502:physiology; D011954:Receptors, Dopamine / Q000502:physiology; D009435:Synaptic Transmission
chemical_list: D004298:Dopamine; D051860:Fragile X Messenger Ribonucleoprotein 1; D011954:Receptors, Dopamine; C497684:Fmr1 protein, mouse